Special Issue "Drug Discovery for Neglected Diseases"
Deadline for manuscript submissions: 30 April 2019
Dr. Valeria Patricia Sülsen
Cátedra de Farmacognosia, Departamento de Farmacología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires
Instituto de Química y Metabolismo del Fármaco (IQUIMEFA) (UBA- CONICET), Junín 956, 1113 Buenos Aires, República Argentina
Website | E-Mail
Phone: (54) -11-52874272
Interests: natural products; sesquiterpene lactones; diterpenes; flavonoids; Asteraceae; antiparasitic activity; antitumor activity; semi-synthetic derivatives
Dr. Albertina Moglioni
Cátedra de Química Medicinal, Departamento de Farmacología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires.
Instituto de Química y Metabolismo del Fármaco (IQUIMEFA) (UBA- CONICET), Junín 956, 1113 Buenos Aires, República Argentina.
Website | E-Mail
Interests: medicinal chemistry; organic synthesis; heterocyclic chemistry; computational chemistry
The Drug Discovery for Neglected Diseases International Congress 2018 (DDNDIC 2018) will be held in Buenos Aires, Argentina, 4–6 December, 2018. This event will be framed in celebration of the 35th anniversary of the creation of the Institute for Drug Chemistry and Metabolism (IQUIMEFA), University of Buenos Aires—National Scientific and Technical Research Council. The 4th Scientific Meeting of the Research Network Natural Products against Neglected Diseases (ResNet NPND) will be carried out together with the DDNDIC 2018. Both events will be held simultaneously at the Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
The aim of this Special Issue is to publish the results presented at the congress, as well as the recent advances made in the field of neglected diseases. The Special Issue of Molecules will be focused on the discovery and development of natural and synthetic drugs for neglected diseases and other diseases having consequences in public health and of high relevance worldwide. Different aspects of parasitic, viral and bacterial diseases, such as Chagas’ disease, African trypanosomiasis, leishmaniasis, dengue and mycetoma, among others will be considered. Vector-borne diseases such as malaria, zika, chikungunya and Argentine hemorrhagic fever will also be included.
Research works dealing with this group of diseases in the areas of natural compounds, drug design, drug synthesis, in vitro and in vivo assays, mechanisms of action, epidemiology and individual and environmental prophylaxis will be considered for publication.
For more details about DDNDIC 18, please click on: http://ddndic.com
Dr. Valeria Sülsen
Dr. Albertina Moglioni
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Neglected tropical diseases
- Drug discovery
- Drug design
- Natural products